Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma

Pathology Research and Practice

Volumn 204, Issue 8, 2008, Pages 527-536

  Yamac, Deniz ^a   Ayyildiz, Talat ^a   Coşkun, Uǧur ^a   Akyürek, Nalan ^a   Dursun, Ayse ^a   Seckin, Selda ^b   Koybasioglu, Fulya ^c  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

^c Department of Immunology/Rheumatology   (Turkey)

Author keywords

Angiogenesis; CD31; COX 2; Gastric cancer; H. pylori

Indexed keywords

CD31 ANTIGEN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, CD31; CYCLOOXYGENASE 2; DISEASE PROGRESSION; FEMALE; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; STOMACH NEOPLASMS; UP-REGULATION;

EID: 47149093561     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.01.002     Document Type: Article

References (54)

1. Akre K., Ekstrom A.M., Signorello L.B., Hansson L.E., and Nyren O. Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br. J. Cancer 84 (2001) 965-968
2. Chen C.N., Sung C.T., Lin M.T., Lee P.H., and Chang K.J. Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma. Ann. Surg. 233 (2001) 183-188
3. Chung I.S. Diagnosis and treatment of Helicobacter pylori infection in Korea. Korean J. Med. 55 (1998) 724-737
4. Cianchi F., Cortesini C., Bechi P., Fantappie O., Messerini L., Vannacci A., Sardi I., Baroni G., Boddi V., Mazzanti R., and Masini E. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 121 (2001) 1339-1347
5. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
6. Guo X.L., Wang L.E., Du S.Y., Fan C.L., Li L., Wang P., and Yuan Y. Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer. World J. Gastroenterol. 9 (2003) 246-249
7. Han S.L., Tang H.J., Hua Y.W., Ji S.Q., and Lin D.X. Expression of COX-2 in stomach cancers and its relation to their biological features. Dig. Surg. 20 (2003) 107-114
8. Joo Y.E., Oh W.T., Rew J.S., Park C.S., Choi S.K., and Kim S.J. Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis. Digestion 66 (2002) 222-229
9. Joo Y.E., Rew J.S., Seo Y.H., Choi S.K., Kim Y.J., Park C.S., and Kim S.J. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. J. Clin. Gastroenterol. 37 (2003) 28-33
10. Kawabe A., Shimada Y., Uchida S., Maeda M., Yamasaki S., Kato M., Hashimoto Y., Ohshio G., Matsumoto M., and Imamura M. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression. J. Surg.Oncol. 80 (2002) 79-88
11. Konturek P.C., Hartwich A., Zuchowicz M., Labza H., Pierzchalski P., Karczewska E., Bielanski W., Hahn E.G., and Konturek S.J. Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer. J. Phys. Pharm. 51 (2000) 737-749
12. Langman M.J., Cheng K.K., Gilman E.A., and Lancashire R.J. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. Br. Med. J. 320 (2000) 1642-1646
13. Lee T.L., Leung W.K., Lau J.Y., Tong J.H., Ng E.K., Chan F.K., Chung S.C., Sung J.J., and To K.F. Inverse association between cyclooxygenase-2 overexpression and microsatellite instability in gastric cancer. Cancer Lett. 168 (2001) 133-140
14. Leung W.K., To K.F., Ng Y.P., Lee T.L., Lau J.Y., Chan F.K., Ng E.K., Chung S.C., and Sung J.J. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer. Br. J. Cancer 84 (2001) 335-339
15. Lim H.Y., Joo H.J., Choi J.H., Yi J.W., Yang M.S., Cho D.Y., Kim H.S., Nam D.K., Lee K.B., and Kim H.C. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin. Cancer Res. 6 (2000) 519-525
16. Maeda K., Chung Y.S., Takatsuka S., Ogawa Y., Sawada T., Yamashita Y., Onoda N., Kato Y., Nitta A., Arimoto Y., et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J. Clin. Oncol. 13 (1995) 477-481
17. Murata H., Kawano S., Tsuji S., Tsuji M., Sawaoka H., Kimura Y., Shiozaki H., and Hori M. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am. J. Gastroenterol. 94 (1999) 451-455
18. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. J. Am. Med. Assoc. 272 (1994) 65-69
19. Ohno R., Yoshinaga K., Fujita T., Hasegawa K., Iseki H., Tsunozaki H., Ichikawa W., Nihei Z., and Sugihara K. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 91 (2001) 1876-1881
20. Peak R.M. Prevention of colorectal cancer through the use of COX-2 selective inhibitors. Prevention of colorectal cancer through the use of COX-2 selective inhibitors. Cancer Chemother. Pharmacol. (2004) 1-14
21. Rajnakova A., Moochhala S., Goh P.M., and Ngoi S. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett. 172 (2001) 177-185
22. Ratnasinghe D., Tangrea J.A., Roth M.J., Dawsey S.M., Anver M., Kasprzak B.A., Hu N., Wang Q.H., and Taylor P.R. Expression of cyclooxygenase-2 in human adenocarcinomas of the gastric cardia and corpus. Oncol. Rep. 6 (1999) 965-968
23. Ratnasinghe D., Tangrea J., Roth M.J., Dawsey S., Hu N., Anver M., Wang Q.H., and Taylor P.R. Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res. 19 (1999) 171-174
24. Ristimaki A., Honkanen N., Jankala H., Sipponen P., and Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 57 (1997) 1276-1280
25. Romano M., Ricci V., Memoli A., Tuccillo C., Di Popolo A., Sommi P., Acquaviva A.M., Del Vecchio Blanco C., Bruni C.B., and Zarrilli R. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J. Biol. Chem. 273 (1998) 28560-28563
26. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., and Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55 (1995) 3785-3789
27. Saukkonen K., Nieminen O., van Rees B., Vilkki S., Harkonen M., Juhola M., Mecklin J.P., Sipponen P., and Ristimaki A. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma. Clin. Cancer Res. 7 (2001) 1923-1931
28. Saukkonen K., Rintahaka J., Sivula A., Buskens C.J., Van Rees B.P., Rio M.C., Haglund C., Van Lanschot J.J., Offerhaus G.J., and Ristimaki A. Cyclooxygenase-2 and gastric carcinogenesis. APMIS 111 (2003) 915-925
29. Schreinemachers D.M., and Everson R.B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5 (1994) 138-146
30. Shi H., Xu J.M., Hu N.Z., and Xie H.J. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J. Gastroenterol. 9 (2003) 1421-1426
31. Sinicrope F.A., and Gill S. Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev. 23 (2004) 63-75
32. Son H.J., Kim Y.H., Park D.I., Kim J.J., Rhee P.L., Paik S.W., Choi K.W., Song S.Y., and Rhee J.C. Interaction between cyclooxygenase-2 and inducible nitric oxide synthase in gastric cancer. J. Clin. Gastroenterol. 33 (2001) 383-388
33. Soydan A.S., Gaffen J.D., Weech P.K., Tremblay N.M., Kargman S., O'Neill G., Bennett A., and Tavares I.A. Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours. Eur. J. Cancer. 33 (1997) 1508-1512
34. Sun W.H., Yu Q., Shen H., Ou X.L., Cao D.Z., Yu T., Qian C., Zhu F., Sun Y.L., Fu X.L., and Su H. Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis. World J. Gastroenterol. 10 (2004) 2809-2813
35. Sung J.J., Leung W.K., Go M.Y., To K.F., Cheng A.S., Ng E.K., and Chan F.K. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am. J. Pathol. 157 (2000) 729-735
36. Tanigawa N., Amaya H., Matsumura M., Shimomatsuya T., Horiuchi T., Muraoka R., and Iki M. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res. 56 (1996) 2671-2676
37. Tanigawa N., Amaya H., Matsumura M., and Shimomatsuya T. Association of tumour vasculature with tumour progression and overall survival of patients with non-early gastric carcinomas. Br. J. Cancer 75 (1997) 566-571
38. Tatsuguchi A., Matsui K., Shinji Y., Gudis K., Tsukui T., Kishida T., Fukuda Y., Sugisaki Y., Tokunaga A., Tajiri T., and Sakamoto C. Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum. Pathol. 35 (2004) 488-495
39. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 341 (1993) 1359-1362
40. Thun M.J., Namboodiri M.M., Calle E.E., Flanders W.D., and Heath Jr. C.W. Aspirin use and risk of fatal cancer. Cancer Res. 3 (1993) 1322-1327
41. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., and DuBois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998) 705-716
42. Tucker O.N., Dannenberg A.J., Yang E.K., Zhang F., Teng L., Daly J.M., Soslow R.A., Masferrer J.L., Woerner B.M., Koki A.T., and Fahey T.J. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 59 (1999) 589-590
43. Uefuji K., Ichikura T., Mochizuki H., and Shinomiya N. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J. Surg. Oncol. 69 (1998) 168-172
44. Uefuji K., Ichikura T., and Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin. Cancer Res. 6 (2000) 135-138
45. Uefuji K., Ichikura T., and Mochizuki H. Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas. J. Surg. Oncol. 76 (2001) 26-30
46. van Rees B.P., Saukkonen K., Ristimaki A., Polkowski W., Tytgat G.N., Drillenburg P., and Offerhaus G.J. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol. 196 (2002) 171-179
47. Williams C.S., Smalley W., and DuBois R.N. Aspirin use and potential mechanisms for colorectal cancer prevention. J. Clin. Invest. 100 (1997) 1325-1329
48. Williams C.S., Mann M., and DuBois R.N. The role of cyclooxygenase in inflammation, cancer and development. Oncogene 18 (1999) 1708-1716
49. Yamagata R., Shimoyama T., Fukuda S., Yoshimura T., Tanaka M., and Munakata A. Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. Eur. J. Gastroenterol. Hepatol. 14 (2002) 359-363
50. Yamamoto H., Itoh F., Fukushima H., Hinoda Y., and Imai K. Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int. J. Cancer 84 (1999) 400-403
51. Xue Y.W., Zhang Q.F., Zhu Z.B., Wang Q., and Fu S.B. Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma. World J. Gastroenterol. 9 (2003) 250-253
52. Yu H.G., Li J.Y., Yang Y.N., Luo H.S., Yu J.P., Meier J.J., Schrader H., Bastian A., Schmidt W.E., and Schmitz F. Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett. 195 (2003) 43-51
53. Zaridze D., Borisova E., Maximovitch D., and Chkhikvadze V. Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. Int. J. Cancer 82 (1999) 473-476
54. Zimmermann K.C., Sarbia M., Weber A.A., Borchard F., Gabbert H.E., and Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59 (1999) 198-204